GENETIC CONSTRUCT FOR TRACKING AND/OR ABLATING QUIESCENT CELLS
A genetic construct is described, the genetic construct comprising: a nucleotide sequence A (Cre + ERT2), the nucleotide sequence A (Cre + ERT2) comprising a nucleotide sequence SEQ ID NO. 1 encoding a recombinase Cre and a sequence SEQ ID NO. 2 encoding a mutant estrogen receptor ERT2; or a nucleot...
Saved in:
Main Authors | , |
---|---|
Format | Patent |
Language | Chinese English |
Published |
21.06.2024
|
Subjects | |
Online Access | Get full text |
Cover
Loading…
Summary: | A genetic construct is described, the genetic construct comprising: a nucleotide sequence A (Cre + ERT2), the nucleotide sequence A (Cre + ERT2) comprising a nucleotide sequence SEQ ID NO. 1 encoding a recombinase Cre and a sequence SEQ ID NO. 2 encoding a mutant estrogen receptor ERT2; or a nucleotide sequence A'comprising a nucleotide sequence SEQ ID NO.3 encoding a diphtheria toxin fragment A (DTA), and comprising a nucleotide sequence B comprising a nucleotide sequence SEQ ID NO.4 encoding an inhibitor p27K-of mutant cyclin dependent kinase (CDK).
描述了遗传构建体,该遗传构建体包含:核苷酸序列A(Cre+ERT2),该核苷酸序列A(Cre+ERT2)包含编码重组酶Cre的核苷酸序列SEQ ID NO.1和编码突变型雌激素受体ERT2的序列SEQ ID NO.2;或核苷酸序列A',该核苷酸序列A'包含编码白喉毒素片段A(DTA)的核苷酸序列SEQ ID NO.3;并且包含核苷酸序列B,该核苷酸序列B包含编码突变型细胞周期蛋白依赖性激酶(CDK)的抑制剂p27K-的核苷酸序列SEQ ID NO.4。 |
---|---|
Bibliography: | Application Number: CN20228073267 |